Cargando…
A prognostic index for multiple myeloma.
The current prognostic systems have failed to identify multiple myeloma (MM) patients who require aggressive therapy. These staging systems do not reliably distinguish patients with different prognoses. This paper explores the possibility of improving the prognostic forecast in MM by considering som...
Autores principales: | Grignani, G., Gobbi, P. G., Formisano, R., Pieresca, C., Ucci, G., Brugnatelli, S., Riccardi, A., Ascari, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074407/ https://www.ncbi.nlm.nih.gov/pubmed/8624271 |
Ejemplares similares
-
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
por: Brugnatelli, S., et al.
Publicado: (1996) -
Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cystostatic policy. Cooperative Group of Study and Treatment of Multiple Myeloma.
por: Riccardi, A., et al.
Publicado: (1994) -
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.
por: Riccardi, A., et al.
Publicado: (1998) -
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study
por: Riccardi, A, et al.
Publicado: (2000) -
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017)